Prudential Financial
CSTL icon

Prudential Financial’s Castle Biosciences CSTL Stock Holding History

Prudential Financial’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,765
Closed -$203K – 2613
2023
Q2 		$203K Sell
14,765
-8,200
-36% -$166K ﹤0.01% 2433
2023
Q1 		$522K Buy
22,965
+11,500
+100% +$281K ﹤0.01% 2044
2022
Q4 		$270K Buy
+11,465
New +$266K ﹤0.01% 2301
2022
Q1 		– Sell
-4,271
Closed -$256K – 2619
2021
Q4 		$256K Sell
4,271
-585
-12% -$30.6K ﹤0.01% 2461
2021
Q3 		$375K Buy
4,856
+955
+24% +$67.2K ﹤0.01% 2246
2021
Q2 		$286K Buy
+3,901
New +$258K ﹤0.01% 2330
2020
Q4 		– Sell
-56,819
Closed -$2.92M – 2455
2020
Q3 		$2.92M Buy
56,819
+21,321
+60% +$949K 0.01% 1142
2020
Q2 		$1.34M Buy
35,498
+26,102
+278% +$892K ﹤0.01% 1514
2020
Q1 		$280K Buy
+9,396
New +$284K ﹤0.01% 2088

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prudential Financial's CSTL Position: Q3 2023 in Review

Prudential Financial sold out of Castle Biosciences (CSTL) in Q3 2023, closing a stake of 14,765 shares — an estimated $203K sold.

Prudential Financial first reported a position in CSTL in Q1 2020 and held it in 9 quarters. The position peaked at $2.92M in Q3 2020. 135 funds tracked by Wall St. Rank hold CSTL as of Q3 2023.

  • Prudential Financial reported no remaining Castle Biosciences position as of Q3 2023 after selling out during the quarter.
  • Prudential Financial sold 14,765 Castle Biosciences shares in Q3 2023, an estimated $203K.
  • Prudential Financial first reported a position in Castle Biosciences in Q1 2020 and held it in 9 quarters.
  • Prudential Financial's Castle Biosciences position peaked at $2.92M in Q3 2020.
  • 135 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2023.

Based on Prudential Financial's 13F filing for Q3 2023, filed 13 Nov 2023.